CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE und Alnylam Pharmaceuticals schließen Vereinbarung zum Start eines neuen klinischen Programms zur Revolutionierung der Diagnose der Erbkrankheit Transthyretin assoziierte Amyloidose („ATTRv“)

CAMBRIDGE, Mass., USA und ROSTOCK, BERLIN & MÜNCHEN, Deutschland, 08. Dezember 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), ein…

Read more

CENTOGENE and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN and MUNICH, Germany, December 08, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a…

Read more

CENTOGENE Expands Partnership with PTC Therapeutics to Generate New Insights for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency

Expanded Partnership Provides Free Biochemical and Genetic Testing to Patients Enrolled in REVEAL CP Study and Expands Global No-Cost Testing Program…

Read more

CENTOGENE Announces Nomination of Jonathan Sheldon to Supervisory Board

CAMBRIDGE, Mass. And ROSTOCK, Germany and BERLIN, Nov. 13, 2020 (Globe Newswire) ─ CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE gibt Führungswechsel bekannt

CAMBRIDGE, Mass. und ROSTOCK und BERLIN, Deutschland, 20. Oktober 2020 -

Centogene N.V. (Nasdaq: CNTG), ein weltweit führendes Unternehmen, welches…

Read more

CENTOGENE Announces Leadership Transition

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company…

Read more

CENTOGENE Increases Full-Year 2020 Guidance

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -

Centogene N.V. (Nasdaq: CNTG), a commercial-stage company…

Read more

Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, and BAARN, the Netherlands, October 14, 2020 (GLOBE NEWSWIRE)

Centogene N.V. (Nasdaq: CNTG), a…

Read more

CENTOGENEs Information Security Management System mit ISO/IEC 27001:2017 Akkreditierung ausgezeichnet

CAMBRIDGE, Mass., ROSTOCK und BERLIN, Deutschland, 28. September, 2020

  • Unternehmen erhält ISO 27001-Akkreditierung für sein Information Security…

Read more

CENTOGENE’s Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 28, 2020 (Globe Newswire)

  • Company awarded ISO 27001 Accreditation for its Information…

Read more

For Further Inquiries Please Contact

Press Contact

Lennart Streibel

Corporate Development, IR & Communication

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads